AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $243,000 | +5.2% | 6,936 | +43.7% | 0.01% | +25.0% |
| Q4 2019 | $231,000 | +8.5% | 4,828 | -26.6% | 0.00% | -33.3% |
| Q3 2019 | $213,000 | -65.2% | 6,582 | -27.5% | 0.01% | -75.0% |
| Q1 2019 | $612,000 | -9.1% | 9,075 | +10.3% | 0.02% | -52.0% |
| Q1 2018 | $673,000 | +28.4% | 8,228 | +4.8% | 0.05% | +19.0% |
| Q3 2017 | $524,000 | -11.9% | 7,851 | -22.9% | 0.04% | -23.6% |
| Q1 2017 | $595,000 | -9.2% | 10,189 | +72.8% | 0.06% | -52.2% |
| Q2 2015 | $655,000 | – | 5,895 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |